URGN
UroGen Pharma·NASDAQ
--
--(--)
--
--(--)
7.37 / 10
Outperform
Technically, URGN scores 7.37 and is classified as Outperform. Dominant bullish candlestick patterns—Long Upper Shadow (8.5/10) and Long Lower Shadow (9.0/10)—outweigh the neutral MACD Golden Cross (4.6/10). The recent five-day indicator mix shows two bullish and one neutral signal, indicating upward momentum with volatility. This technical posture supports the idea of riding near-term strength.
Analysis Checks(2/3)
Long Upper Shadow
Score8.5/10
Win Rate66.67%
Hist. Signals33
Avg Return12.56%
Score8.5/10
Win Rate66.67%
Hist. Signals33
Avg Return12.56%
MACD Golden Cross
Score4.6/10
Win Rate55.56%
Hist. Signals9
Avg Return0.13%
Score4.6/10
Win Rate55.56%
Hist. Signals9
Avg Return0.13%
Long Lower Shadow
Score9/10
Win Rate73.68%
Hist. Signals38
Avg Return7.56%
Score9/10
Win Rate73.68%
Hist. Signals38
Avg Return7.56%
Long Upper Shadow
Score8.5/10
Win Rate66.67%
Hist. Signals33
Avg Return12.56%
Score8.5/10
Win Rate66.67%
Hist. Signals33
Avg Return12.56%
Long Lower Shadow
Score9/10
Win Rate73.68%
Hist. Signals38
Avg Return7.56%
Score9/10
Win Rate73.68%
Hist. Signals38
Avg Return7.56%
MACD Golden Cross
Score4.6/10
Win Rate55.56%
Hist. Signals9
Avg Return0.13%
Score4.6/10
Win Rate55.56%
Hist. Signals9
Avg Return0.13%
Technical Analysis of URGN?
- URGN presents a Outperform setup with a Technical Score of 7.37/10. Key technical indicators highlight an RSI of 51.87 and a MACD of 0.36, with the trend anchored by the 50-Day SMA at 22.50. Traders should monitor key support at 19.86 and resistance at 21.69.
